First medical contact in patients with STEMI and its impact on time to diagnosis; an explorative cross-sectional

Ingela Thylén1, Maria Ericsson2, Karin Hellström Ängerud3

  • 1Department of Cardiology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.

BMJ Open
|April 23, 2015
PubMed

Insights

Patients with ST-elevation myocardial infarction (STEMI) using Swedish Healthcare Direct (SHD) as first medical contact instead of Emergency Medical Services (EMS) experience longer diagnosis times. This delay may negatively impact patient prognosis.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Public Health

Background:

  • ST-elevation myocardial infarction (STEMI) is a critical medical emergency.
  • Timely diagnosis and treatment are crucial for STEMI patient outcomes.
  • Understanding patient first medical contact (FMC) pathways is essential for optimizing emergency care.

Purpose of the Study:

  • To determine the extent to which patients with STEMI use Swedish Healthcare Direct (SHD) versus Emergency Medical Services (EMS) as their FMC.
  • To identify factors influencing the choice between SHD and EMS for STEMI patients.
  • To analyze the impact of FMC choice on the time from symptom onset to diagnosis in STEMI patients.

Main Methods:

  • Multicenter, cross-sectional study conducted in Sweden.
  • Inclusion of consecutive STEMI patients admitted within 24 hours.
  • Data collection on patient demographics, FMC, reasons for FMC choice, and time to diagnosis.

Main Results:

  • While 83% arrived by ambulance, only 51% used EMS as FMC; 21% used SHD, 14% contacted primary care, and 14% went directly to the emergency room.
  • Reasons for not calling EMS included perceived faster personal transport (40%) and underestimation of symptom severity (30%).
  • Contacting SHD as FMC was associated with longer symptom onset to diagnosis times (1:59 hours) compared to EMS (1:21 hours).

Conclusions:

  • Utilizing alternatives to EMS, such as SHD, as the primary contact for STEMI significantly prolongs diagnosis time.
  • Delayed diagnosis due to non-EMS contact may adversely affect patient prognosis.
  • However, accessible services like SHD may encourage some patients to seek care who might otherwise delay seeking medical attention.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
468
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
493
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
791
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
466
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K